Bruno CLEMENT, DR
Research topics and scientific objectives
Education and main positions held
After a Ph.D. in Cellular and Molecular Biology, Bruno Clément joined the NIH in Bethesda MD, as a post-doctoral fellow for 3 years. In 1985, he was appointed at Inserm, and in 1992, he headed a group focused on liver cancer and the tumor microenvironment, in the “Liver Research” Inserm unit, in Rennes. He was member of the editorial board of Hepatology in 1997-2007. From 1998 to 2003, he was appointed at the Ministry of Research as a counselor and deputy-director of the Biotechnology Department. He was involved in the implementation of the Law on Innovation, the Biological Ressources Centres program, and the Biotechnology clusters. He was member of several international committees on biobanks and biotechnology, e.g. in OECD and in the European Commission. From 2003 to 2007 he was appointed counselor of the general director of Inserm for biobanks and biotechnology development, and scientific director of INSERM-Transfert, the TTO subsidiary of Inserm. He is currently CSO of the national BIOBANQUES infrastructure. In 2010 he was appointed Director of the Inserm unit n°991 “Liver, Metabolisms and Cancer”. Bruno Clément has published 130 papers in international peer-reviewed journals in the field of liver physiopathology, the role of the microenvironment in tumor progression and the development of innovative diagnosis and therapeutic tools for the treatment of liver cancers.
See more : http://cvscience.aviesan.fr/cv/1179/bruno-clement